Antimicrobial Agents and Chemotherapy · 1997 · 89 citations · 24 references
Life SciencesBiochemistryInfectious DiseasesMolecular VirologyRedox BiochemistryVirologyCopper ToxicityMetal ToxicityCopper-mediated OxidationDna Damage InductionFree Radical KineticsFree Radical ScavengingHydrogen Peroxide TreatmentRadical ScavengersRate Constant DeterminationSuperoxide Dismutase Function
The inactivation of herpes simplex virus (HSV) by copper was enhanced by the following reducing agents at the indicated relative level: ascorbic acid >> hydrogen peroxide > cysteine. Treatment of HSV-infected cells with combinations of Cu(II) and ascorbate completely inhibited virus plaque formation to below 0.006% of the infectious virus input, while it maintained 30% viability for the host mammalian cells. The logarithm of the surviving fraction of HSV mediated by 1 mg of Cu(II) per liter and 100 mg of reducing agent per liter followed a linear relationship with the reaction time, in which the kinetic rate constant for each reducing agent was -0.87 min(-1) (r = 0.93) for ascorbate, -0.10 min(-1) (r = 0.97) for hydrogen peroxide, and -0.04 min(-1) (r = 0.97) for cysteine. The protective effects of metal chelators and catalase, the lack of effect of superoxide dismutase, and the partial protection conferred by free-radical scavengers suggest that the mechanism of copper-mediated HSV inactivation is similar to that previously reported for copper-mediated DNA damage. The sensitivity exhibited by HSV to Cu(II) and reducing agents, particularly ascorbate, might be useful in the development of therapeutic antiviral agents.
24
The Pharmacological Basis of Therapeutics
American Journal of Health-System Pharmacy · 1976 · 8.2K citations
On the cytotoxicity of vitamin C and metal ions
Amram Samuni, J. Aronovitch, D. Godinger et al. · European Journal of Biochemistry · 1983 · 326 citations · Full text